Evidence map›Paper›PMID 31735037›Full record

ArticleAnnals of palliative medicine2020

Interdisciplinary palliative care for people with advanced Parkinson's disease: a view from the home.

Jori E Fleisher, Ellen C Klostermann, Serena P Hess, Jeanette Lee, Erica Myrick, Joshua Chodosh

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Annals of palliative medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 4 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 4 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. What's in a name? reframing advanced Parkinson's disease as a multidimensional state.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Palliative Care in Movement Disorders: an Evolving Field.Current neurology and neuroscience reports · 2021
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jori E FleisherDepartment of Neurological Sciences, Rush University Medical Center, Chicago, USA. Jori_Fleisher@rush.edu.
Ellen C KlostermannDepartment of Neurological Sciences, Rush University Medical Center, Chicago, USA.
Serena P HessDepartment of Neurological Sciences, Rush University Medical Center, Chicago, USA.
Jeanette LeeDepartment of Neurological Sciences, Rush University Medical Center, Chicago, USA.
Erica MyrickDepartment of Neurological Sciences, Rush University Medical Center, Chicago, USA.
Joshua ChodoshDepartment of Medicine, New York University School of Medicine, New York, USA; Medicine Service, VA New York Harbor Healthcare System, New York, USA.
Rush University Medical Center · USNew York University · US

Funding

Research Education ComponentP30AG066512 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Ricardo S Osorio · 2020 to 2026
$28.4M
Dementia with Lewy Bodies Consortium - Supplement for ASL sequenceU01NS100610 · NINDS · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI DOUGLAS R GALASKO, JAMES Bruce LEVERENZ · 2016 to 2026
$15.6M
Reaching the Most Vulnerable: A Novel Model of Care in Advanced Parkinson's DiseaseK23NS097615 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI FLEISHER, JORI ERIN · 2017 to 2021
$921k
NIA NIH HHS P30 AG066512NINDS NIH HHS K23 NS097615NINDS NIH HHS L30 NS084235NINDS NIH HHS U01 NS100610
6 · The paper itself

Abstract

backgroundAdvanced Parkinson's disease (PD) is a multidimensional neurodegenerative condition with motor and non-motor symptoms contributing to increasing disability and decreasing quality of life. As the disease progresses, patients may become homebound and estranged from neurological care, with dire consequences. We describe the increasing epidemiologic burden of and individual risks faced by patients with palliative-stage PD and their caregivers.

methodsWith the aim of mitigating these risks, we designed and iterated two models of interdisciplinary home visits to maintain continuity of care and illuminate the unmet needs and barriers to care faced by this population. We describe both models in detail, with data on feasibility and patient-centered outcomes achieved in the initial model, and baseline characteristics of participants in the ongoing expanded model. Finally, we illustrate the scope and common themes of such palliative care-informed home visits with two cases.

resultsThe pilot model involved over 380 visits with 109 individual patients. Among those patients, PD severity worsened by nearly 12 points annually on the Unified Parkinson's Disease Rating Scale (UPDRS), without a corresponding decline in quality of life. In an ongoing study of the second iteration of the model, 52 patient-caregiver dyads have completed their initial visit, with 44% bearing a diagnosis of dementia and the majority requiring an assistive device or being bedbound. Two cases highlight the critical importance of thorough medication reconciliation and home safety assessment in the comprehensive evaluation and management of such patients.

conclusionsAs our population ages, therapies increase, and the number of individuals living with advanced PD and related disorders grows, so too does the imperative to recognize and address the palliative care needs of such patients and families. For many, home may be a viable, and perhaps optimal, site for this care.

Indexed as

House CallsPalliative CarePatient Care TeamAgedFemaleHumansMaleParkinson DiseaseHome visitsinterdisciplinaryneurodegenerative diseaseParkinson’s disease (PD)

Identifiers

PMID31735037
PMCPMC7341729
OpenAlexW2979699520

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.